Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Open accessThe DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
Many neurogenetic disorders are caused by the mutation of ubiquitously expressed genes. One such disorder, spinal muscular atrophy, is caused by loss or mutation of the survival motor neuron1 gene (SMN1), leading to reduced SMN protein levels and a selective dysfunction of motor neurons. SMN, together with partner proteins, functions in the assembly of small nuclear ribonucleoproteins (snRNPs), which are important for pre-mRNA splicing. It has also been suggested that SMN might function in the assembly of other ribonucleoprotein complexes. Two hypotheses have been proposed to explain the molecular dysfunction that gives rise to spinal muscular atrophy (SMA) and its specificity to a particular group of neurons. The first hypothesis states that the loss of SMN's well-known function in snRNP assembly causes an alteration in the splicing of a specific gene (or genes). The second hypothesis proposes that SMN is crucial for the transport of mRNA in neurons and that disruption of this function results in SMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also of particular relevance is the possible role of HuD in spinal muscular atrophy (SMA), a disease that results in degeneration of spinal cord motor neurons due to deletion or loss-of-function mutations in the survival of motor neuron 1 (SMN1) gene, resulting in inadequate expression of functional SMN protein (Burghes and Beattie 2009).”
From Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction (2013) · cites this paper as Burghes and Beattie 2009
Experimental — accuracy not yet measuredIn the citing paper
“SMA is a devastating neurodegenerative disease resulting from progressive loss of motor neurons.1”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative isoform regulation in human tissue transcriptomes
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., & Burge, C. B. (2008) · Nature · doi:10.1038/nature07509 · Cited by 5,181
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Muscle Biopsy: A Practical Approach
Dubowitz, V., Sewry, C. A., Oldfors, A., & Lane, R. J. M. (2020) · Cited by 1,335
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107 · cited 1×
“cgi?id=105400">amyotrophic lateral sclerosis (caused by mutations in superoxide dismutase 1 ( SOD1 )”
BackgroundCorrelation between severity and SMN protein level in spinal muscular atrophy
Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 954
Self-citationNon-coding RNAs: lessons from the small nuclear and small nucleolar RNAs
Matera, A. G., Terns, R. M., & Terns, M. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2124 · Cited by 877
A novel nuclear structure containing the survival of motor neurons protein.
Liu, Q., & Dreyfuss, G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00725.x · Cited by 780
Cited by
Items 201–300 of 825
Axonal Regeneration and Neuronal Function Are Preserved in Motor Neurons Lacking ß-Actin In Vivo
Cheever, T. R., Olson, E. A., & Ervasti, J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017768 · Cited by 60
Lee, A. J. H., Awano, T., Park, G.-H., & Monani, U. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046353 · Cited by 60
Quality control of assembly-defective U1 snRNAs by decapping and 5′-to-3′ exonucleolytic digestion
Shukla, S., & Parker, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412614111 · Cited by 60
Sabra, M., Texier, P., El Maalouf, J., & Lomonte, P. (2013) · Journal of Cell Science · doi:10.1242/jcs.126003 · Cited by 43
Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives
Lejman, J., Panuciak, K., Nowicka, E., Mastalerczyk, A., Wojciechowska, K., & Lejman, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021130 · Cited by 58
Pathological impact of SMN2 mis‐splicing in adult SMA mice
Sahashi, K., Ling, K., Hua, Y., Wilkinson, J. E., Nomakuchi, T. T., Rigo, F., Hung, G., Xu, D. S., Jiang, Y., Lin, R. Z., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302567 · Cited by 58
Workman, E., Kolb, S. J., & Battle, D. J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.051 · Cited by 57
Wadman, R. I., Stam, M., Jansen, M., van der Weegen, Y., Wijngaarde, C. A., Harschnitz, O., Sodaar, P., Braun, K. P. J., Dooijes, D., Lemmink, H. H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167087 · Cited by 57
Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder
Kour, S., Rajan, D. S., Fortuna, T. R., Anderson, E. N., Ward, C., Lee, Y., Lee, S., Shin, Y. B., Chae, J., Choi, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22627-w · Cited by 57
Paez-Colasante, X., Seaberg, B. L., Martinez, T. L., Kong, L., Sumner, C. J., & Rimer, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075866 · Cited by 56
Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy
Li, Y.-J., Chen, T., Wu, Y.-Z., & Tseng, Y.-H. (2020) · Nutrients · doi:10.3390/nu12123842 · Cited by 56
Tukov, F. F., Mansfield, K. G., Milton, M., Meseck, E. K., Penraat, K. A., Chand, D. H., & Hartmann, A. (2022) · Human Gene Therapy · doi:10.1089/hum.2021.255 · Cited by 56
Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse
McGovern, V. L., Massoni‐Laporte, A., Wang, X., Le, T. T., Le, H., Beattie, C. E., Rich, M. M., & Burghes, A. H. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132364 · Cited by 55
Self-citationDysregulation of ubiquitin homeostasis and beta-catenin signaling promote spinal muscular atrophy
Young, R. (2015) · Cited by 54
Effective heritable gene knockdown in zebrafish using synthetic microRNAs
Giacomotto, J., Rinkwitz, S., & Becker, T. S. (2015) · Nature Communications · doi:10.1038/ncomms8378 · Cited by 53
Drosophila SMN complex proteins Gemin2, Gemin3, and Gemin5 are components of U bodies
Cauchi, R. J., Sánchez‐Pulido, L., & Liu, J. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.05.001 · Cited by 53
Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
Ziemka‐Nałęcz, M., Jaworska, J., Sypecka, J., & Zalewska, T. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly073 · Cited by 53
Sarvestany, A. A., Hunter, G., Tavendale, A., Lamont, D. J., Hurtado, M. L., Graham, L. C., Wishart, T. M., & Gillingwater, T. H. (2014) · Journal of Proteome Research · doi:10.1021/pr500492j · Cited by 52
Garcia, E. L., Lu, Z., Meers, M. P., Praveen, K., & Matera, A. G. (2013) · RNA · doi:10.1261/rna.038919.113 · Cited by 52
Totzeck, A., Stolte, B., Kizina, K., Bolz, S., Schlag, M., Thimm, A., Kleinschnitz, C., & Hagenacker, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215397 · Cited by 52
Blijlevens, M., Li, J., & van Beusechem, V. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105110 · Cited by 52
Survival motor neuron protein reduction deregulates autophagy in spinal cord motoneurons in vitro
Garcerá, A., Bahí, N., Periyakaruppiah, A., Arumugam, S., & Soler, R. M. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.209 · Cited by 52
Distinct pathways leading to TDP-43-induced cellular dysfunctions
Yamashita, M., Nonaka, T., Hirai, S., Miwa, A., Okado, H., Arai, T., Hosokawa, M., Akiyama, H., & Hasegawa, M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu152 · Cited by 44
Spinal muscular atrophy: diagnosis, treatment and future prospects
Baioni, M. T. C., & Ambiel, C. R. (2010) · Jornal de Pediatria · doi:10.2223/jped.1988 · Cited by 51
Treatment Advances in Spinal Muscular Atrophy
Bharucha-Goebel, D. X., & Kaufmann, P. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0798-y · Cited by 51
Diagnostic Challenge and Neuromuscular Junction Contribution to ALS Pathogenesis
Campanari, M., Bourefis, A.-R., & Kabashi, E. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00068 · Cited by 51
Fayzullina, S., & Martin, L. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093329 · Cited by 51
Iyer, C. C., McGovern, V. L., Murray, J. D., Gombash, S. E., Zaworski, P. G., Foust, K. D., Janssen, P. M. L., & Burghes, A. H. M. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv332 · Cited by 50
Self-citationPraveen, K., Wen, Y., Gray, K. M., Noto, J. J., Patlolla, A. R., Duyne, G. D. V., & Matera, A. G. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004489 · Cited by 50
Piazzon, N., Schlotter, F., Lefebvre, S., Dodré, M., Méreau, A., Soret, J., Besse, A., Barkats, M., Bordonné, R., Branlant, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1224 · Cited by 50
Garcerá, A., Mincheva-Tasheva, S., Gou-Fàbregas, M., Caraballo-Miralles, V., Lladó, J., Comella, J. X., & Soler, R. M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.02.003 · Cited by 50
Turner, B. J., Alfazema, N., Sheean, R. K., Sleigh, J. N., Davies, K. E., Horne, M. K., & Talbot, K. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.030 · Cited by 49
The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
Arnold, W. D., McGovern, V. L., Sanchez, B., Li, J., Corlett, K. M., Kolb, S. J., Rutkove, S. B., & Burghes, A. H. M. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.12.014 · Cited by 50
Self-citationBuettner, J. M., Longang, J. K. S., Gerstner, F., Apel, K. S., Blanco-Redondo, B., Sowoidnich, L., Janzen, E., Langenhan, T., Wirth, B., & Simon, C. M. (2021) · iScience · doi:10.1016/j.isci.2021.103376 · Cited by 49
Day, J. W., Finkel, R. S., Mercuri, E., Swoboda, K. J., Menier, M., van Olden, R., Tauscher-Wisniewski, S., & Mendell, J. R. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.02.014 · Cited by 48
“SMA is a progressive neurologic disease caused by decreased amounts of the ubiquitously expressed survival motor neuron (SMN) protein, which is required for survival of motor neurons.(1,6) The most severe cases, generally associated with two copies of the backup gene, SMN2, result in death or the need for permanent ve…”
BackgroundCurrent developments of gene therapy in human diseases
Liu, F., Li, R., Zhu, Z., Yang, Y., & Lu, F. (2024) · MedComm · doi:10.1002/mco2.645 · Cited by 48
Mutsaers, C. A., Lamont, D. J., Hunter, G., Wishart, T. M., & Gillingwater, T. H. (2013) · Genome Medicine · doi:10.1186/gm498 · Cited by 48
Plastin 3 is upregulated in iPSC-derived motoneurons from asymptomatic SMN1-deleted individuals
Heesen, L., Peitz, M., Torres‐Benito, L., Hölker, I., Hupperich, K., Dobrindt, K., Jungverdorben, J., Ritzenhofen, S., Weykopf, B., Eckert, D., et al. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2084-y · Cited by 48
Nizzardo, M., Simone, C., Dametti, S., Salani, S., Ulzi, G., Pagliarani, S., Rizzo, F., Frattini, E., Pagani, F., Bresolin, N., et al. (2015) · Scientific Reports · doi:10.1038/srep11746 · Cited by 48
Antisense oligonucleotides and spinal muscular atrophy: skipping along: Figure 1.
Burghes, A. H. M., & McGovern, V. L. (2010) · Genes & Development · doi:10.1101/gad.1961710 · Cited by 48
Self-citationThe function of spliceosome components in open mitosis
Hofmann, J. C., Husedzinovic, A., & Gruß, O. J. (2010) · Nucleus · doi:10.4161/nucl.1.6.13328 · Cited by 47
Maretina, M. A., Zheleznyakova, G. Y., Lanko, K., Egorova, A., Баранов, В. С., & Kiselev, A. (2018) · Current Genomics · doi:10.2174/1389202919666180101154916 · Cited by 48
Emerging Roles of Gemin5: From snRNPs Assembly to Translation Control
Martínez-Salas, E., Buh, A. E., & Francisco‐Velilla, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113868 · Cited by 47
Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
Kotulska, K., Fattal‐Valevski, A., & Haberlová, J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.726468 · Cited by 47
Miho, M., Harris, A. W., Kingham, B. F., Lumpkin, C. J., Opdenaker, L. M., McCahan, S. M., Wang, W., & Butchbach, M. E. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106818 · Cited by 47
Coque, E., Raoul, C., & Bowerman, M. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00271 · Cited by 46
Laird, A. S., Mackovski, N., Rinkwitz, S., Becker, T. S., & Giacomotto, J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw044 · Cited by 46
Cardiac involvement in patients with spinal muscular atrophies.
Palladino, A., Passamano, L., Taglia, A., D′Ambrosio, P., Scutifero, M., Cecio, M. R., Picillo, E., Viggiano, E., Torre, Luca, F. D., et al. (2011) · PubMed Central · Cited by 46
How do SMA-linked mutations of SMN1 lead to structural/functional deficiency of the SMA protein?
Li, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178519 · Cited by 46
Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations
McMillan, H. J., Kernohan, K. D., Yeh, E., Amburgey, K., Boyd, J. R., Campbell, C., Dowling, J. J., Gonorazky, H. D., Marcadier, J., Tarnopolsky, M. A., et al. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.229 · Cited by 46
TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals
Sahashi, K., Hua, Y., Ling, K. K. Y., Hung, G., Rigo, F., Horev, G., Katsuno, M., Sobue, G., Ko, C.-P., Bennett, C. F., et al. (2012) · Genes & Development · doi:10.1101/gad.197418.112 · Cited by 40
The intriguing case of motor neuron disease: ALS and SMA come closer
Achsel, T., Barabino, S. M. L., Cozzolino, M., & Carrì, M. T. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130142 · Cited by 45
Satoh, M., Chan, J. Y. F., Ross, S. J., Ceribelli, A., Cavazzana, I., Franceschini, F., Li, Y., Reeves, W. H., Sobel, E. S., & Chan, E. K. L. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30349 · Cited by 45
Proteomic assessment of a cell model of spinal muscular atrophy
Wu, C.-Y., Whye, D., Glazewski, L., Choe, L. H., Kerr, D. A., Lee, K. H., Mason, R. W., & Wang, W. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-25 · Cited by 45
Miller, N., Feng, Z., Edens, B. M., Yang, B., Shi, H., Sze, C. C., Hong, B. T., Su, S. C., Cantu, J. A., Topczewski, J., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3716-14.2015 · Cited by 40
Genetic circuitry of Survival motor neuron , the gene underlying spinal muscular atrophy
Sen, A., Dimlich, D. N., Guruharsha, K. G., Kankel, M. W., Hori, K., Yokokura, T., Brachat, S., Richardson, D. L., Loureiro, J., Sivasankaran, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301738110 · Cited by 44
Synaptic homeostats: latent plasticity revealed at the Drosophila neuromuscular junction
Goel, P., & Dickman, D. K. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03732-3 · Cited by 44
Assays for the Identification and Prioritization of Drug Candidates for Spinal Muscular Atrophy
Cherry, J. J., Kobayashi, D. T., Lynes, M. M., Naryshkin, N. N., Tiziano, F. D., Zaworski, P. G., Rubin, L. L., & Jarecki, J. (2014) · Assay and Drug Development Technologies · doi:10.1089/adt.2014.587 · Cited by 43
Chen, T., & Chen, J. (2019) · eLife · doi:10.7554/elife.50848 · Cited by 43
Functional Roles of Long Non-coding RNAs in Motor Neuron Development and Disease
Chen, K., & Chen, J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00628-z · Cited by 43
R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy
Cuartas, J., & Gangwani, L. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.826608 · Cited by 43
SMN deficiency does not induce oxidative stress in SMA iPSC-derived astrocytes or motor neurons
Patitucci, T. N., & Ebert, A. D. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv489 · Cited by 43
Hunter, G., Powis, R. A., Jones, R. A., Groen, E. J. N., Shorrock, H. K., Lane, F. M., Zheng, Y., Sherman, D. L., Brophy, P., & Gillingwater, T. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw141 · Cited by 43
SMN - A chaperone for nuclear RNP social occasions?
Raimer, A. C., Gray, K. M., & Matera, A. G. (2016) · RNA Biology · doi:10.1080/15476286.2016.1236168 · Cited by 43
Why do motor neurons degenerate? Actualisation in the pathogenesis of amyotrophic lateral sclerosis
Riancho, J., Gonzalo, I., Ruiz‐Soto, M., & Berciano, J. (2017) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.12.019 · Cited by 42
Synaptic defects in spinal muscular atrophy animal models
Torres‐Benito, L., Ruiz, R., & Tabares, L. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20912 · Cited by 42
Perera, N. D., Sheean, R. K., Crouch, P. J., White, A. R., Horne, M. K., & Turner, B. J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw247 · Cited by 41
Donlin-Asp, P., Rossoll, W., & Bassell, G. J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12621 · Cited by 41
The Gemin Associates of Survival Motor Neuron Are Required for Motor Function in Drosophila
Borg, R. M., & Cauchi, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083878 · Cited by 41
Advances in understanding the role of disease-associated proteins in spinal muscular atrophy
Hosseinibarkooie, S., Schneider, S. M., & Wirth, B. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1345631 · Cited by 40
The multiple lives of DEAD-box RNA helicase DP103/DDX20/Gemin3
Curmi, F., & Cauchi, R. J. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180016 · Cited by 40
Moments in autophagy and disease: Past and present
Wen, X., Yang, Y., & Klionsky, D. J. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100966 · Cited by 40
ETS-domain transcription factor Elk-1 mediates neuronal survival: SMN as a potential target
Demir, O., Ayşit, N., Onder, Z., Türkel, N., Öztürk, G., Sharrocks, A. D., & Kurnaz, I. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.012 · Cited by 40
Jablonka, S., & Sendtner, M. (2017) · Gene Therapy · doi:10.1038/gt.2017.46 · Cited by 40
Therapy development in spinal muscular atrophy
Sendtner, M. (2010) · Nature Neuroscience · doi:10.1038/nn.2565 · Cited by 39
Cerveró, C., Montull, N., Tarabal, O., Piedrafita, L., Esquerda, J. E., & Calderó, J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0399-x · Cited by 39
Narayanan, N., Wang, Z., Li, L., & Yang, Y. (2017) · Cell Discovery · doi:10.1038/celldisc.2016.48 · Cited by 39
Schellino, R., Boido, M., Borsello, T., & Vercelli, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00308 · Cited by 39
Ojala, K. S., Reedich, E. J., DiDonato, C. J., & Meriney, S. D. (2021) · Brain Sciences · doi:10.3390/brainsci11020194 · Cited by 39
Arnold, W. D., Severyn, S. A., Zhao, S., Kline, D., Linsenmayer, M., Kelly, K., Tellez, M., Bartlett, A., Heintzman, S., Reynolds, J., et al. (2021) · BMJ Neurology Open · doi:10.1136/bmjno-2021-000164 · Cited by 39
Self-citationOnasemnogene abeparvovec for the treatment of spinal muscular atrophy
McMillan, H. J., Proud, C. M., Farrar, M. A., Alexander, I. E., Muntoni, F., & Servais, L. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2066471 · Cited by 39
Ishikawa, H., Nobe, Y., Izumikawa, K., Yoshikawa, H., Miyazawa, N., Terukina, G., Kurokawa, N., Taoka, M., Yamauchi, Y., Nakayama, H., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1271 · Cited by 39
Zhao, X., Feng, Z., Ling, K., Mollin, A., Sheedy, J., Yeh, S., Petruska, J. M., Narasimhan, J., Dakka, A., Welch, E. M., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw062 · Cited by 39
MotomiRs: miRNAs in Motor Neuron Function and Disease
Hawley, Z. C. E., Campos‐Melo, D., Droppelmann, C. A., & Strong, M. J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00127 · Cited by 39
Gem Depletion: Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy Crossover
Cauchi, R. J. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12242 · Cited by 38
Cacciottolo, R., Ciantar, J., Lanfranco, M., Borg, R. M., Vassallo, N., Bordonné, R., & Cauchi, R. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-53508-4 · Cited by 38
Minor Intron Splicing from Basic Science to Disease
Marabti, E. E., Malek, J. A., & Younis, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116062 · Cited by 38
Spinal Muscular Atrophy and the Antiapoptotic Role of Survival of Motor Neuron (SMN) Protein
Anderton, R. S., Meloni, B. P., Mastaglia, F. L., & Boulos, S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8399-5 · Cited by 38
Exploring the multifaceted roles of heat shock protein B8 (HSPB8) in diseases
Li, F., Xiao, H., Hu, Z., Zhou, F., & Yang, B. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.03.003 · Cited by 38
SMN-Inducing Compounds For The Treatment Of Spinal Muscular Atrophy
Lorson, M. A., & Lorson, C. L. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.131 · Cited by 37
Valsecchi, V., Anzilotti, S., Serani, A., Laudati, G., Brancaccio, P., Guida, N., Cuomo, O., Pignataro, G., & Annunziato, L. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.013 · Cited by 37
Muntoni, F., Bertini, E., Comi, G. P., Kirschner, J., Łusakowska, A., Mercuri, E. M., Scoto, M., van der Pol, W. L., Vuillerot, C., Burdeska, A., et al. (2020) · Neuromuscular Disorders · doi:10.1016/j.nmd.2020.10.008 · Cited by 37
Rindt, H., Buckley, D. M., Vale, S. M., Krogman, M. M., Rose, F. F., Garcia, M. L., & Lorson, C. L. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.10.012 · Cited by 37
New and developing therapies in spinal muscular atrophy
Kariyawasam, D. S. T., Carey, K. A., Jones, K., & Farrar, M. A. (2018) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2018.03.003 · Cited by 37
Axonal mRNA translation in neurological disorders
Lin, J. Q., van Tartwijk, F. W., & Holt, C. E. (2020) · RNA Biology · doi:10.1080/15476286.2020.1822638 · Cited by 36
Huo, Q., Kayikci, M., Odermatt, P., Meyer, K., Michels, O., Saxena, S., Ule, J., & Schümperli, D. (2014) · RNA Biology · doi:10.1080/15476286.2014.996494 · Cited by 36
Oligomeric Properties of Survival Motor Neuron·Gemin2 Complexes
Gupta, K., Martin, R. S., Sharp, R. B., Sarachan, K. L., Ninan, N. S., & Duyne, G. D. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.667279 · Cited by 36
Spinal muscular atrophy: from tissue specificity to therapeutic strategies
Iascone, D. M., Henderson, C. E., & Lee, J. (2015) · F1000Prime Reports · doi:10.12703/p7-04 · Cited by 35
Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion
Martin, J. E., Nguyen, T. T., Grunseich, C., Nofziger, J. H., Lee, P. R., Fields, D. W., Fischbeck, K. H., & Foran, E. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3472-16.2017 · Cited by 35
Spinal Muscular Atrophy in the Treatment Era
Waldrop, M. A., & Elsheikh, B. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2020.03.002 · Cited by 35
Metadata
- Authors
- Burghes, A. H. M., & Beattie, C. E.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Burghes, Arthur H. M.
- Venue
- Nature Reviews Neuroscience
- Published
- 2009-07-08
- Volume
- 10
- Issue
- 8
- Pages
- 597-609
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC2853768
- OpenAlex
- W2148071380
- Cited by
- 723
- References
- 176
- Citations by year
- 2026: 24 · 2025: 27 · 2024: 28 · 2023: 33 · 2022: 33 · 2021: 41 · 2020: 38 · 2019: 44 · 2018: 46 · 2017: 54 · 2016: 50 · 2015: 50 · 2014: 46 · 2013: 56 · 2012: 43
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS038650, R01NS041649)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- spinal muscular atrophy, survival motor neuron protein, SMN1, motor neuron dysfunction, small nuclear ribonucleoproteins, pre-mRNA splicing, ribonucleoprotein assembly, mRNA transport, loss-of-function mutations, neurodegeneration
- MeSH terms
- Humans, Models, Biological, Motor Neurons, Muscular Atrophy, Spinal, Ribonucleoproteins, Small Nuclear, Survival of Motor Neuron 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.